Type 2 Diabetes Mellitus With Insulin Resistance Therapeutics
1. Actos patent expiration
Treatment: Method of reducing side effects of active components admin to a diabetic by admin a chemical compound having formula (incl pioglitazone) in combination with an insulin secretion enhancer; A method of ...
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6303640 | TAKEDA PHARMS USA | Pharmaceutical composition |
Aug, 2016
(9 years ago) | |
| US6150384 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
| US6166042 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
| US6150383 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
| US5965584 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
| US6271243 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
| US6329404 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
| US6172090 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
| US6211205 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
| US6166043 | TAKEDA PHARMS USA | Pharmaceutical composition |
Jun, 2016
(9 years ago) | |
Drugs and Companies using PIOGLITAZONE HYDROCHLORIDE ingredient
Market Authorisation Date: 15 July, 1999
Dosage: TABLET
How can I launch a generic of ACTOS before it's drug patent expiration?
More Information on Dosage
ACTOS family patents
